News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
News Conference News ESC 2025 Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD L.A. McKeown September 05, 2025
News Daily News POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies L.A. McKeown July 15, 2025
News Daily News GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease L.A. McKeown June 12, 2025
News Conference News CX Symposium 2025 Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK L.A. McKeown April 24, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2025 Caitlin E. Cox April 01, 2025
News Daily News ACC 2025 STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients L.A. McKeown March 29, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Daily News Take Heed of Sex Differences in Peripheral Vascular Disease: AHA Michael O'Riordan March 13, 2025
News Daily News Philips Recalls Tack Endovascular Systems and Stops Distribution L.A. McKeown March 03, 2025
News Daily News Survey Calls Out Implicit Bias in Peripheral Vascular Care L.A. McKeown February 28, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2025 Shelley Wood February 28, 2025
News Daily News FDA Issues Early Alert About Risks of Peripheral Atherectomy Device L.A. McKeown February 07, 2025
News Daily News Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many L.A. McKeown January 16, 2025
News Daily News As More Peripheral Interventions Go Radial, the AHA Offers Some Insights L.A. McKeown December 12, 2024
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024